企業プロフィール
RXDX 株価・ニュース・カタリスト
- ティッカー:
- RXDX
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価変動の要因
Current closing-price context is not available for RXDX.
企業概要
事業概要
Prometheus Biosciences was an immunology-focused biotechnology company centered on precision medicine for inflammatory bowel disease before being acquired by Merck. Its story was built around translating biomarker-driven biology into targeted treatments.
所在地とセクター分類
Prometheus was headquartered in the United States and traded on NASDAQ before the acquisition. It sat in immunology and precision biotechnology.
ビジネスモデルの特徴
The company’s value was driven by clinical readouts, biomarker strategy, and the potential to create a differentiated treatment path in inflammatory disease. Investors watched data quality, target validation, and the strategic interest in its platform.
バイオ業界での位置付け
Prometheus was a premium precision-immunology biotech and one of the more compelling catalyst-driven names of its era. Since it has been acquired, it is now part of biotech M&A history rather than the live public-company universe.
今後のカタリスト
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。